R. Cosentini (Milan, Italy), A. De Roux (Berlin, Germany)
Elevated troponin and creatinine levels are associated with higher mortality in community-acquired pneumonia
A. M. Higton, D. Chen, A. S. Y. Sim, Z. Y. Teo, F. Chua (London, United Kingdom)
|  |
Utility of bronchoalveolar lavage in acutely unwell haematological patients
S. Ponnambath Abdul Gaffoor, L. M. Jones (Leeds, United Kingdom)
| |
Community acquired pneumonia: What has changed in 10 years?
P. J. Marcos, R. Dacal, H. Gómez, M. Santalla, G. Cortez (Ourense, Spain)
| |
Etiology of community-acquired pneumoniae in young adults
A. Martynova, E. Nosuch (Vladivostok, Russian Federation)
| |
Evaluation of galactomannan (GM) antigen in patients with rheumatoid arthritis (RA)
W. Tanaka, H. Tamiya, K. Matsuta, S. Noguchi, M. Horie, H. Yoshihara, M. Kawakami, M. Suzuki, Y. Sakamoto (Tokyo, Japan)
| |
Empyema thoracis: 250 pts: One surgeon‘s experience
K. Athanassiadi, S. Pispirigkou, M. Kolokotroni, E. Balis, K. Kotsifas (Athens, Greece)
|  |
Vitamin D deficiency relates to airway bacterial load in Wegeners granulomatosis
A. Wood, A. Richter, R. Stockley, L. Harper, D. Thickett (Birmingham, United Kingdom)
| |
Biological markers in hospitalised patients with community acquired pneumonia (CAP)
E. Mincholé, A. B. Lasierra, S. Fandos, D. Nieto, M. A. Ruiz, M. J. Revillo, A. García de Jalón, S. Bello (Zaragoza, Spain)
| |
Incidence, risk factors and outcomes of nonresolving pneumonia
G. Salomoni, S. Aliberti, C. Travierso, V. Betti, L. C. Morlacchi, S. Seghezzi, J. A. Ramirez, F. Blasi (Milan, Italy; Louisville, United States Of America)
| |
Pentraxin 3 in community-acquired pneumonia: A pilotal study
A. Voza, S. Aliberti, E. Baldassarre, B. Bottazzi, F. Piffer, V. Rossetti, D. Legnani, A. Mantovani, F. Blasi (Rozzano (MI), Milan, Italy)
| |
Comorbidities and community acquired pneumonia (CAP) with PSI IV-V
J. N. Sancho-Chust, E. Chiner, E. Fernandez-Fabrellas, J. Blanquer, A. Cervera, F. Sanz, C. Senent, M. C. Aguar (Valencia, Spain)
| |
Communitty acquired pneumonia in very elderly patients: A characteristical approach
A. Cervera, M. C. Aguar, E. Fernandez-Fabrellas, E. Chiner, F. Sanz, Grupo CAP-AVANT Comunidad Valenciana (Valencia, Spain)
| |
Inhaled drugs as risk factors for community-acquired pneumonia
J. Almirall, I. Bolibar, M. Serra, E. Palomera, J. Roig, I. Hospital, E. Carandell, M. Agustí, P. Ayuso, A. Estela, M. De la Torre, A. Torres (Mataró, Barcelona, Valls, Palma de Mallorca, Tàrrega, Valencia, Maó, Spain; Escaldes-Engordany, Andorra)
| |
Outpatient management of community acquired pneumonia using severity prediction tools: A systematic review and meta-analysis
A. Akram, J. Chalmers, A. Hill (United Kingdom)
| |
The effects of temperature and humidity on hospital admissions with community-acquired pneumonia across two seasons
J. Mamo, J. Micallef, R. Callus, S. Montefort (Nottingham, United Kingdom; Birkirkara, Malta)
| |
Influence of medical comorbidities in patients with community acquired pneumonia
L. A. Ruiz, S. Pedrero, A. Gomez, N. Marina, I. Seijas, M. Alfonso, M. Intxausti, R. Zalacain (Barakaldo, Spain)
| |
Community-acquired pneumonia (CAP) in the elderly: Prediction of mortality by physical symptoms, laboratory values and radiographic features on admission
I. Djordjevic, T. Pejcic, D. Nastasijevic-Borovac, T. Radjenovic-Petkovic (Nis, Republic Of Serbia)
| |
Influence of antibiotic pre-treatment on prognostic value of CRB-65 score -Results from the German competence network CAPNETZ
S. Krueger, S. Ewig, N. Suttorp, T. Welte (Bochum, Berlin, Germany)
| |
Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP)
F. J. F. Herth, H. Knape, U. Frank, M. Simpfendoerfer, J. Braitmayer, I. Berwanger, I. Bruder, S. Rode, Y. Wirth (Stuttgart, Germany)
| |